Pulmonary Arterial Hypertension Panel Test code: 02351 • 10–21 days turnaround time Up to 14 genes

Pulmonary Arterial Hypertension Panel

This panel is intended for individuals with a clinical diagnosis or suspected diagnosis of pulmonary arterial hypertension (PAH). It analyzes genes that are definitively associated with hereditary forms of PAH.

Individuals with clinical symptoms or findings suggestive of PAH may benefit from genetic testing to:

• Establish or confirm a diagnosis
• Identify an underlying inherited genetic cause
• Clarify potential disease and health risks
• Support individualized medical management
• Guide appropriate monitoring and risk-reduction strategies
• Provide information for genetic counseling and family testing

Family Testing:
Asymptomatic family members of an individual with a known pathogenic variant associated with PAH may also benefit from targeted genetic testing. Identifying whether a family member carries the familial variant may help clarify their individual risk and support appropriate clinical evaluation and management.

Genetic information may also help family members and healthcare professionals make informed decisions regarding potential risk factors and medications that may be inappropriate or require careful consideration for individuals with an increased risk of PAH.

Important: Medication decisions should always be made in consultation with a qualified healthcare professional. Genetic testing should be interpreted in the context of the individual's clinical history, family history, and other diagnostic findings.